nodes	percent_of_prediction	percent_of_DWPC	metapath
Pantoprazole—ABCB1—Lisinopril—dilated cardiomyopathy	0.199	0.532	CbGbCtD
Pantoprazole—ABCB1—Spironolactone—dilated cardiomyopathy	0.175	0.468	CbGbCtD
Pantoprazole—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00418	0.00686	CcSEcCtD
Pantoprazole—Blood uric acid increased—Furosemide—dilated cardiomyopathy	0.00417	0.00685	CcSEcCtD
Pantoprazole—Herpes zoster—Lisinopril—dilated cardiomyopathy	0.00409	0.0067	CcSEcCtD
Pantoprazole—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00393	0.00645	CcSEcCtD
Pantoprazole—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.00377	0.00618	CcSEcCtD
Pantoprazole—Bladder pain—Furosemide—dilated cardiomyopathy	0.00371	0.00608	CcSEcCtD
Pantoprazole—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00358	0.00587	CcSEcCtD
Pantoprazole—Mental disability—Furosemide—dilated cardiomyopathy	0.00356	0.00584	CcSEcCtD
Pantoprazole—Breast pain—Lisinopril—dilated cardiomyopathy	0.00353	0.00578	CcSEcCtD
Pantoprazole—Jaundice cholestatic—Lisinopril—dilated cardiomyopathy	0.0035	0.00574	CcSEcCtD
Pantoprazole—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.00344	0.00564	CcSEcCtD
Pantoprazole—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.00342	0.00561	CcSEcCtD
Pantoprazole—Viral infection—Lisinopril—dilated cardiomyopathy	0.00341	0.00559	CcSEcCtD
Pantoprazole—Photosensitivity—Furosemide—dilated cardiomyopathy	0.00339	0.00556	CcSEcCtD
Pantoprazole—Arthropathy—Lisinopril—dilated cardiomyopathy	0.00338	0.00555	CcSEcCtD
Pantoprazole—Cough increased—Lisinopril—dilated cardiomyopathy	0.00336	0.00551	CcSEcCtD
Pantoprazole—Alopecia—Spironolactone—dilated cardiomyopathy	0.00334	0.00549	CcSEcCtD
Pantoprazole—Deafness—Furosemide—dilated cardiomyopathy	0.00333	0.00546	CcSEcCtD
Pantoprazole—Gout—Lisinopril—dilated cardiomyopathy	0.00329	0.00541	CcSEcCtD
Pantoprazole—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.00327	0.00537	CcSEcCtD
Pantoprazole—Creatinine increased—Lisinopril—dilated cardiomyopathy	0.00323	0.0053	CcSEcCtD
Pantoprazole—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00317	0.0052	CcSEcCtD
Pantoprazole—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.00315	0.00517	CcSEcCtD
Pantoprazole—Thirst—Furosemide—dilated cardiomyopathy	0.00313	0.00513	CcSEcCtD
Pantoprazole—Neck pain—Lisinopril—dilated cardiomyopathy	0.00311	0.00511	CcSEcCtD
Pantoprazole—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00306	0.00501	CcSEcCtD
Pantoprazole—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.003	0.00493	CcSEcCtD
Pantoprazole—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.00299	0.0049	CcSEcCtD
Pantoprazole—Influenza like illness—Lisinopril—dilated cardiomyopathy	0.00299	0.0049	CcSEcCtD
Pantoprazole—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.00299	0.0049	CcSEcCtD
Pantoprazole—Malaise—Spironolactone—dilated cardiomyopathy	0.00297	0.00487	CcSEcCtD
Pantoprazole—Cystitis—Lisinopril—dilated cardiomyopathy	0.00297	0.00487	CcSEcCtD
Pantoprazole—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00295	0.00484	CcSEcCtD
Pantoprazole—Fluid retention—Lisinopril—dilated cardiomyopathy	0.00292	0.00479	CcSEcCtD
Pantoprazole—Neuropathy—Lisinopril—dilated cardiomyopathy	0.00289	0.00474	CcSEcCtD
Pantoprazole—Photophobia—Lisinopril—dilated cardiomyopathy	0.00289	0.00474	CcSEcCtD
Pantoprazole—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.00279	0.00457	CcSEcCtD
Pantoprazole—Bladder pain—Lisinopril—dilated cardiomyopathy	0.00278	0.00456	CcSEcCtD
Pantoprazole—Discomfort—Spironolactone—dilated cardiomyopathy	0.00277	0.00455	CcSEcCtD
Pantoprazole—Dehydration—Furosemide—dilated cardiomyopathy	0.00277	0.00454	CcSEcCtD
Pantoprazole—ATP4B—Ion transport by P-type ATPases—PLN—dilated cardiomyopathy	0.00273	0.173	CbGpPWpGaD
Pantoprazole—Confusional state—Spironolactone—dilated cardiomyopathy	0.00271	0.00445	CcSEcCtD
Pantoprazole—Hypertonia—Lisinopril—dilated cardiomyopathy	0.0027	0.00442	CcSEcCtD
Pantoprazole—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00269	0.00441	CcSEcCtD
Pantoprazole—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00268	0.0044	CcSEcCtD
Pantoprazole—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00268	0.0044	CcSEcCtD
Pantoprazole—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00263	0.00432	CcSEcCtD
Pantoprazole—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00259	0.00425	CcSEcCtD
Pantoprazole—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.00258	0.00423	CcSEcCtD
Pantoprazole—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.00257	0.00421	CcSEcCtD
Pantoprazole—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00255	0.00418	CcSEcCtD
Pantoprazole—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.00254	0.00417	CcSEcCtD
Pantoprazole—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00252	0.00414	CcSEcCtD
Pantoprazole—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.00252	0.00413	CcSEcCtD
Pantoprazole—Eczema—Lisinopril—dilated cardiomyopathy	0.00248	0.00408	CcSEcCtD
Pantoprazole—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.00248	0.00408	CcSEcCtD
Pantoprazole—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.00245	0.00402	CcSEcCtD
Pantoprazole—ATP4A—Ion transport by P-type ATPases—PLN—dilated cardiomyopathy	0.00243	0.155	CbGpPWpGaD
Pantoprazole—Injury—Lisinopril—dilated cardiomyopathy	0.00243	0.00399	CcSEcCtD
Pantoprazole—Libido decreased—Lisinopril—dilated cardiomyopathy	0.00241	0.00395	CcSEcCtD
Pantoprazole—Somnolence—Spironolactone—dilated cardiomyopathy	0.00239	0.00392	CcSEcCtD
Pantoprazole—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00238	0.0039	CcSEcCtD
Pantoprazole—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.00236	0.00387	CcSEcCtD
Pantoprazole—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00235	0.00385	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00232	0.00381	CcSEcCtD
Pantoprazole—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00232	0.00381	CcSEcCtD
Pantoprazole—Arthritis—Lisinopril—dilated cardiomyopathy	0.0023	0.00377	CcSEcCtD
Pantoprazole—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00227	0.00373	CcSEcCtD
Pantoprazole—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.00224	0.00368	CcSEcCtD
Pantoprazole—Diplopia—Lisinopril—dilated cardiomyopathy	0.00223	0.00366	CcSEcCtD
Pantoprazole—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.00223	0.00366	CcSEcCtD
Pantoprazole—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.00223	0.00366	CcSEcCtD
Pantoprazole—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00222	0.00364	CcSEcCtD
Pantoprazole—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00222	0.00363	CcSEcCtD
Pantoprazole—Sweating—Furosemide—dilated cardiomyopathy	0.0022	0.00361	CcSEcCtD
Pantoprazole—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00217	0.00356	CcSEcCtD
Pantoprazole—Face oedema—Lisinopril—dilated cardiomyopathy	0.00216	0.00354	CcSEcCtD
Pantoprazole—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00214	0.00351	CcSEcCtD
Pantoprazole—Urticaria—Spironolactone—dilated cardiomyopathy	0.00214	0.0035	CcSEcCtD
Pantoprazole—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00213	0.00349	CcSEcCtD
Pantoprazole—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.00209	0.00343	CcSEcCtD
Pantoprazole—Dehydration—Lisinopril—dilated cardiomyopathy	0.00208	0.00341	CcSEcCtD
Pantoprazole—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00203	0.00334	CcSEcCtD
Pantoprazole—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00202	0.00331	CcSEcCtD
Pantoprazole—Breast disorder—Lisinopril—dilated cardiomyopathy	0.00202	0.00331	CcSEcCtD
Pantoprazole—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.00201	0.0033	CcSEcCtD
Pantoprazole—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.00201	0.0033	CcSEcCtD
Pantoprazole—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.002	0.00328	CcSEcCtD
Pantoprazole—Visual impairment—Furosemide—dilated cardiomyopathy	0.00198	0.00326	CcSEcCtD
Pantoprazole—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00198	0.00325	CcSEcCtD
Pantoprazole—Gastritis—Lisinopril—dilated cardiomyopathy	0.00198	0.00324	CcSEcCtD
Pantoprazole—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00195	0.00319	CcSEcCtD
Pantoprazole—Asthma—Lisinopril—dilated cardiomyopathy	0.00193	0.00317	CcSEcCtD
Pantoprazole—Influenza—Lisinopril—dilated cardiomyopathy	0.00193	0.00317	CcSEcCtD
Pantoprazole—Eye disorder—Furosemide—dilated cardiomyopathy	0.00192	0.00316	CcSEcCtD
Pantoprazole—Tinnitus—Furosemide—dilated cardiomyopathy	0.00192	0.00315	CcSEcCtD
Pantoprazole—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00191	0.00314	CcSEcCtD
Pantoprazole—Pruritus—Spironolactone—dilated cardiomyopathy	0.0019	0.00312	CcSEcCtD
Pantoprazole—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.00189	0.0031	CcSEcCtD
Pantoprazole—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00188	0.00308	CcSEcCtD
Pantoprazole—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00188	0.00308	CcSEcCtD
Pantoprazole—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00186	0.00305	CcSEcCtD
Pantoprazole—Bronchitis—Lisinopril—dilated cardiomyopathy	0.00186	0.00305	CcSEcCtD
Pantoprazole—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00184	0.00302	CcSEcCtD
Pantoprazole—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00184	0.00302	CcSEcCtD
Pantoprazole—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.00183	0.00301	CcSEcCtD
Pantoprazole—Dysuria—Lisinopril—dilated cardiomyopathy	0.0018	0.00296	CcSEcCtD
Pantoprazole—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.00179	0.00294	CcSEcCtD
Pantoprazole—Malnutrition—Furosemide—dilated cardiomyopathy	0.00179	0.00294	CcSEcCtD
Pantoprazole—Dizziness—Spironolactone—dilated cardiomyopathy	0.00178	0.00292	CcSEcCtD
Pantoprazole—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00178	0.00292	CcSEcCtD
Pantoprazole—Flatulence—Furosemide—dilated cardiomyopathy	0.00177	0.0029	CcSEcCtD
Pantoprazole—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00176	0.00289	CcSEcCtD
Pantoprazole—Weight increased—Lisinopril—dilated cardiomyopathy	0.00176	0.00288	CcSEcCtD
Pantoprazole—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00176	0.00288	CcSEcCtD
Pantoprazole—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00175	0.00286	CcSEcCtD
Pantoprazole—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00174	0.00286	CcSEcCtD
Pantoprazole—Pneumonia—Lisinopril—dilated cardiomyopathy	0.00173	0.00284	CcSEcCtD
Pantoprazole—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00172	0.00283	CcSEcCtD
Pantoprazole—Depression—Lisinopril—dilated cardiomyopathy	0.00172	0.00282	CcSEcCtD
Pantoprazole—Vomiting—Spironolactone—dilated cardiomyopathy	0.00171	0.0028	CcSEcCtD
Pantoprazole—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.00171	0.0028	CcSEcCtD
Pantoprazole—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.0017	0.00278	CcSEcCtD
Pantoprazole—Rash—Spironolactone—dilated cardiomyopathy	0.0017	0.00278	CcSEcCtD
Pantoprazole—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00169	0.00278	CcSEcCtD
Pantoprazole—Vision blurred—Furosemide—dilated cardiomyopathy	0.00169	0.00277	CcSEcCtD
Pantoprazole—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00169	0.00277	CcSEcCtD
Pantoprazole—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00169	0.00277	CcSEcCtD
Pantoprazole—Headache—Spironolactone—dilated cardiomyopathy	0.00168	0.00276	CcSEcCtD
Pantoprazole—Jaundice—Lisinopril—dilated cardiomyopathy	0.00168	0.00275	CcSEcCtD
Pantoprazole—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00167	0.00274	CcSEcCtD
Pantoprazole—Anaemia—Furosemide—dilated cardiomyopathy	0.00166	0.00272	CcSEcCtD
Pantoprazole—Sweating—Lisinopril—dilated cardiomyopathy	0.00165	0.00271	CcSEcCtD
Pantoprazole—Agitation—Furosemide—dilated cardiomyopathy	0.00165	0.0027	CcSEcCtD
Pantoprazole—Haematuria—Lisinopril—dilated cardiomyopathy	0.00164	0.00269	CcSEcCtD
Pantoprazole—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00163	0.00267	CcSEcCtD
Pantoprazole—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00162	0.00266	CcSEcCtD
Pantoprazole—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00161	0.00265	CcSEcCtD
Pantoprazole—Vertigo—Furosemide—dilated cardiomyopathy	0.00161	0.00264	CcSEcCtD
Pantoprazole—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00161	0.00263	CcSEcCtD
Pantoprazole—Leukopenia—Furosemide—dilated cardiomyopathy	0.0016	0.00263	CcSEcCtD
Pantoprazole—Nausea—Spironolactone—dilated cardiomyopathy	0.0016	0.00262	CcSEcCtD
Pantoprazole—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00155	0.00254	CcSEcCtD
Pantoprazole—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00154	0.00253	CcSEcCtD
Pantoprazole—Hallucination—Lisinopril—dilated cardiomyopathy	0.00154	0.00252	CcSEcCtD
Pantoprazole—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00153	0.00252	CcSEcCtD
Pantoprazole—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00153	0.0025	CcSEcCtD
Pantoprazole—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00152	0.0025	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00152	0.00249	CcSEcCtD
Pantoprazole—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00151	0.00248	CcSEcCtD
Pantoprazole—Dry mouth—Furosemide—dilated cardiomyopathy	0.00149	0.00245	CcSEcCtD
Pantoprazole—Confusional state—Furosemide—dilated cardiomyopathy	0.00147	0.00242	CcSEcCtD
Pantoprazole—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00146	0.0024	CcSEcCtD
Pantoprazole—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00146	0.0024	CcSEcCtD
Pantoprazole—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00144	0.00236	CcSEcCtD
Pantoprazole—Shock—Furosemide—dilated cardiomyopathy	0.00144	0.00236	CcSEcCtD
Pantoprazole—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00143	0.00235	CcSEcCtD
Pantoprazole—Flushing—Lisinopril—dilated cardiomyopathy	0.00143	0.00235	CcSEcCtD
Pantoprazole—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00143	0.00235	CcSEcCtD
Pantoprazole—Skin disorder—Furosemide—dilated cardiomyopathy	0.00142	0.00233	CcSEcCtD
Pantoprazole—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00141	0.00232	CcSEcCtD
Pantoprazole—Anorexia—Furosemide—dilated cardiomyopathy	0.00139	0.00229	CcSEcCtD
Pantoprazole—Chills—Lisinopril—dilated cardiomyopathy	0.00139	0.00227	CcSEcCtD
Pantoprazole—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00138	0.00226	CcSEcCtD
Pantoprazole—Hypotension—Furosemide—dilated cardiomyopathy	0.00137	0.00224	CcSEcCtD
Pantoprazole—Alopecia—Lisinopril—dilated cardiomyopathy	0.00137	0.00224	CcSEcCtD
Pantoprazole—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00135	0.00222	CcSEcCtD
Pantoprazole—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00134	0.00221	CcSEcCtD
Pantoprazole—Flatulence—Lisinopril—dilated cardiomyopathy	0.00133	0.00217	CcSEcCtD
Pantoprazole—Tension—Lisinopril—dilated cardiomyopathy	0.00132	0.00217	CcSEcCtD
Pantoprazole—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00132	0.00216	CcSEcCtD
Pantoprazole—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00131	0.00215	CcSEcCtD
Pantoprazole—Nervousness—Lisinopril—dilated cardiomyopathy	0.00131	0.00214	CcSEcCtD
Pantoprazole—Back pain—Lisinopril—dilated cardiomyopathy	0.0013	0.00213	CcSEcCtD
Pantoprazole—Somnolence—Furosemide—dilated cardiomyopathy	0.0013	0.00213	CcSEcCtD
Pantoprazole—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00129	0.00212	CcSEcCtD
Pantoprazole—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00127	0.00209	CcSEcCtD
Pantoprazole—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00127	0.00208	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00126	0.00207	CcSEcCtD
Pantoprazole—Fatigue—Furosemide—dilated cardiomyopathy	0.00126	0.00207	CcSEcCtD
Pantoprazole—Tremor—Lisinopril—dilated cardiomyopathy	0.00126	0.00207	CcSEcCtD
Pantoprazole—Pain—Furosemide—dilated cardiomyopathy	0.00125	0.00205	CcSEcCtD
Pantoprazole—Constipation—Furosemide—dilated cardiomyopathy	0.00125	0.00205	CcSEcCtD
Pantoprazole—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00125	0.00205	CcSEcCtD
Pantoprazole—Anaemia—Lisinopril—dilated cardiomyopathy	0.00124	0.00204	CcSEcCtD
Pantoprazole—Angioedema—Lisinopril—dilated cardiomyopathy	0.00123	0.00202	CcSEcCtD
Pantoprazole—Malaise—Lisinopril—dilated cardiomyopathy	0.00121	0.00199	CcSEcCtD
Pantoprazole—Vertigo—Lisinopril—dilated cardiomyopathy	0.00121	0.00198	CcSEcCtD
Pantoprazole—Syncope—Lisinopril—dilated cardiomyopathy	0.00121	0.00198	CcSEcCtD
Pantoprazole—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00121	0.00198	CcSEcCtD
Pantoprazole—Leukopenia—Lisinopril—dilated cardiomyopathy	0.0012	0.00197	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.0012	0.00196	CcSEcCtD
Pantoprazole—Palpitations—Lisinopril—dilated cardiomyopathy	0.00119	0.00195	CcSEcCtD
Pantoprazole—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00118	0.00194	CcSEcCtD
Pantoprazole—Cough—Lisinopril—dilated cardiomyopathy	0.00117	0.00193	CcSEcCtD
Pantoprazole—Urticaria—Furosemide—dilated cardiomyopathy	0.00116	0.00191	CcSEcCtD
Pantoprazole—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00116	0.0019	CcSEcCtD
Pantoprazole—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00116	0.0019	CcSEcCtD
Pantoprazole—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00114	0.00188	CcSEcCtD
Pantoprazole—Chest pain—Lisinopril—dilated cardiomyopathy	0.00114	0.00188	CcSEcCtD
Pantoprazole—Myalgia—Lisinopril—dilated cardiomyopathy	0.00114	0.00188	CcSEcCtD
Pantoprazole—Anxiety—Lisinopril—dilated cardiomyopathy	0.00114	0.00187	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00114	0.00187	CcSEcCtD
Pantoprazole—Discomfort—Lisinopril—dilated cardiomyopathy	0.00113	0.00186	CcSEcCtD
Pantoprazole—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00112	0.00184	CcSEcCtD
Pantoprazole—Confusional state—Lisinopril—dilated cardiomyopathy	0.00111	0.00182	CcSEcCtD
Pantoprazole—Oedema—Lisinopril—dilated cardiomyopathy	0.0011	0.0018	CcSEcCtD
Pantoprazole—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.0011	0.0018	CcSEcCtD
Pantoprazole—Infection—Lisinopril—dilated cardiomyopathy	0.00109	0.00179	CcSEcCtD
Pantoprazole—Shock—Lisinopril—dilated cardiomyopathy	0.00108	0.00177	CcSEcCtD
Pantoprazole—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00108	0.00177	CcSEcCtD
Pantoprazole—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00107	0.00176	CcSEcCtD
Pantoprazole—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00107	0.00176	CcSEcCtD
Pantoprazole—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00107	0.00175	CcSEcCtD
Pantoprazole—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00106	0.00174	CcSEcCtD
Pantoprazole—Asthenia—Furosemide—dilated cardiomyopathy	0.00105	0.00172	CcSEcCtD
Pantoprazole—Anorexia—Lisinopril—dilated cardiomyopathy	0.00105	0.00172	CcSEcCtD
Pantoprazole—Pruritus—Furosemide—dilated cardiomyopathy	0.00103	0.0017	CcSEcCtD
Pantoprazole—Hypotension—Lisinopril—dilated cardiomyopathy	0.00103	0.00168	CcSEcCtD
Pantoprazole—Diarrhoea—Furosemide—dilated cardiomyopathy	0.001	0.00164	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.001	0.00164	CcSEcCtD
Pantoprazole—Insomnia—Lisinopril—dilated cardiomyopathy	0.000993	0.00163	CcSEcCtD
Pantoprazole—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000985	0.00162	CcSEcCtD
Pantoprazole—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000978	0.00161	CcSEcCtD
Pantoprazole—Somnolence—Lisinopril—dilated cardiomyopathy	0.000976	0.0016	CcSEcCtD
Pantoprazole—ATP4B—Ion channel transport—RYR2—dilated cardiomyopathy	0.000972	0.0617	CbGpPWpGaD
Pantoprazole—Dizziness—Furosemide—dilated cardiomyopathy	0.000967	0.00159	CcSEcCtD
Pantoprazole—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000966	0.00159	CcSEcCtD
Pantoprazole—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000954	0.00157	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000947	0.00155	CcSEcCtD
Pantoprazole—Fatigue—Lisinopril—dilated cardiomyopathy	0.000946	0.00155	CcSEcCtD
Pantoprazole—ATP4B—Ion channel transport—PLN—dilated cardiomyopathy	0.000945	0.06	CbGpPWpGaD
Pantoprazole—Pain—Lisinopril—dilated cardiomyopathy	0.000939	0.00154	CcSEcCtD
Pantoprazole—Constipation—Lisinopril—dilated cardiomyopathy	0.000939	0.00154	CcSEcCtD
Pantoprazole—Vomiting—Furosemide—dilated cardiomyopathy	0.00093	0.00153	CcSEcCtD
Pantoprazole—Rash—Furosemide—dilated cardiomyopathy	0.000922	0.00151	CcSEcCtD
Pantoprazole—Dermatitis—Furosemide—dilated cardiomyopathy	0.000921	0.00151	CcSEcCtD
Pantoprazole—Headache—Furosemide—dilated cardiomyopathy	0.000916	0.0015	CcSEcCtD
Pantoprazole—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000904	0.00148	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000897	0.00147	CcSEcCtD
Pantoprazole—Urticaria—Lisinopril—dilated cardiomyopathy	0.000872	0.00143	CcSEcCtD
Pantoprazole—Nausea—Furosemide—dilated cardiomyopathy	0.000869	0.00143	CcSEcCtD
Pantoprazole—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000868	0.00142	CcSEcCtD
Pantoprazole—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000868	0.00142	CcSEcCtD
Pantoprazole—ATP4A—Ion channel transport—RYR2—dilated cardiomyopathy	0.000866	0.055	CbGpPWpGaD
Pantoprazole—ATP4A—Ion channel transport—PLN—dilated cardiomyopathy	0.000843	0.0535	CbGpPWpGaD
Pantoprazole—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000809	0.00133	CcSEcCtD
Pantoprazole—Asthenia—Lisinopril—dilated cardiomyopathy	0.000787	0.00129	CcSEcCtD
Pantoprazole—Pruritus—Lisinopril—dilated cardiomyopathy	0.000776	0.00127	CcSEcCtD
Pantoprazole—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000751	0.00123	CcSEcCtD
Pantoprazole—Dizziness—Lisinopril—dilated cardiomyopathy	0.000726	0.00119	CcSEcCtD
Pantoprazole—Vomiting—Lisinopril—dilated cardiomyopathy	0.000698	0.00114	CcSEcCtD
Pantoprazole—Rash—Lisinopril—dilated cardiomyopathy	0.000692	0.00114	CcSEcCtD
Pantoprazole—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000691	0.00113	CcSEcCtD
Pantoprazole—Headache—Lisinopril—dilated cardiomyopathy	0.000688	0.00113	CcSEcCtD
Pantoprazole—Nausea—Lisinopril—dilated cardiomyopathy	0.000652	0.00107	CcSEcCtD
Pantoprazole—ATP4B—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000338	0.0215	CbGpPWpGaD
Pantoprazole—ABCB1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.000329	0.0209	CbGpPWpGaD
Pantoprazole—ATP4B—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000329	0.0209	CbGpPWpGaD
Pantoprazole—ATP4B—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000329	0.0209	CbGpPWpGaD
Pantoprazole—ATP4B—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000306	0.0194	CbGpPWpGaD
Pantoprazole—ATP4A—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000301	0.0191	CbGpPWpGaD
Pantoprazole—ATP4A—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000293	0.0186	CbGpPWpGaD
Pantoprazole—ATP4A—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000293	0.0186	CbGpPWpGaD
Pantoprazole—ATP4A—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000273	0.0173	CbGpPWpGaD
Pantoprazole—CYP2C19—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.00021	0.0133	CbGpPWpGaD
Pantoprazole—ATP4B—Ion channel transport—RAF1—dilated cardiomyopathy	0.000192	0.0122	CbGpPWpGaD
Pantoprazole—ATP4A—Ion channel transport—RAF1—dilated cardiomyopathy	0.000171	0.0108	CbGpPWpGaD
Pantoprazole—CYP1A2—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000163	0.0104	CbGpPWpGaD
Pantoprazole—SLCO1B1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000145	0.00923	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000112	0.00712	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000105	0.00669	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	9.32e-05	0.00592	CbGpPWpGaD
Pantoprazole—CYP2C19—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	9.3e-05	0.0059	CbGpPWpGaD
Pantoprazole—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	8.48e-05	0.00538	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	7.84e-05	0.00498	CbGpPWpGaD
Pantoprazole—SLCO1B1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	7.6e-05	0.00482	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	7.54e-05	0.00479	CbGpPWpGaD
Pantoprazole—SLCO1B1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	7.39e-05	0.00469	CbGpPWpGaD
Pantoprazole—SLCO1B1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	7.39e-05	0.00469	CbGpPWpGaD
Pantoprazole—CYP1A2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	7.24e-05	0.0046	CbGpPWpGaD
Pantoprazole—ABCG2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	7.04e-05	0.00447	CbGpPWpGaD
Pantoprazole—SLCO1B1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	6.87e-05	0.00436	CbGpPWpGaD
Pantoprazole—ABCG2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	6.84e-05	0.00435	CbGpPWpGaD
Pantoprazole—ABCG2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	6.84e-05	0.00435	CbGpPWpGaD
Pantoprazole—ATP4B—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	6.67e-05	0.00424	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	6.57e-05	0.00417	CbGpPWpGaD
Pantoprazole—ABCG2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	6.36e-05	0.00404	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	6.11e-05	0.00388	CbGpPWpGaD
Pantoprazole—ATP4A—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.95e-05	0.00378	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	5.89e-05	0.00374	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	5.75e-05	0.00365	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	5.41e-05	0.00343	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	5.25e-05	0.00333	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—ANKRD1—dilated cardiomyopathy	5e-05	0.00317	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	4.93e-05	0.00313	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	4.71e-05	0.00299	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—TAZ—dilated cardiomyopathy	4.7e-05	0.00298	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—ANKRD1—dilated cardiomyopathy	4.63e-05	0.00294	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	4.48e-05	0.00285	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—TAZ—dilated cardiomyopathy	4.35e-05	0.00276	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—SDHA—dilated cardiomyopathy	4.25e-05	0.0027	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	4.21e-05	0.00268	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—SDHA—dilated cardiomyopathy	3.93e-05	0.0025	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	3.8e-05	0.00241	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	3.7e-05	0.00235	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	3.7e-05	0.00235	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	3.44e-05	0.00218	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	3.23e-05	0.00205	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	3.23e-05	0.00205	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	3.08e-05	0.00195	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	3.08e-05	0.00195	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	3.02e-05	0.00191	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	2.91e-05	0.00185	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	2.85e-05	0.00181	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.59e-05	0.00164	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	2.56e-05	0.00163	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.52e-05	0.0016	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	2.5e-05	0.00159	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	2.5e-05	0.00159	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	2.41e-05	0.00153	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	2.35e-05	0.00149	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	2.34e-05	0.00148	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.27e-05	0.00144	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	2.2e-05	0.00139	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	2.18e-05	0.00138	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	2.13e-05	0.00135	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	2e-05	0.00127	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	1.99e-05	0.00126	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	1.89e-05	0.0012	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	1.88e-05	0.00119	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	1.7e-05	0.00108	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	1.54e-05	0.000978	CbGpPWpGaD
Pantoprazole—SLCO1B1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.5e-05	0.000952	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	1.45e-05	0.00092	CbGpPWpGaD
Pantoprazole—ABCG2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.39e-05	0.000881	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.33e-05	0.000844	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	1.31e-05	0.000832	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	1.3e-05	0.000823	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.29e-05	0.000821	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	1.23e-05	0.000784	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.21e-05	0.000769	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.18e-05	0.000749	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.17e-05	0.00074	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—GPX1—dilated cardiomyopathy	1.15e-05	0.000732	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—CD36—dilated cardiomyopathy	1.12e-05	0.000713	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—GPX1—dilated cardiomyopathy	1.07e-05	0.000678	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.06e-05	0.000674	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—CD36—dilated cardiomyopathy	1.04e-05	0.00066	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.04e-05	0.000657	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—AGT—dilated cardiomyopathy	1.01e-05	0.000642	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.01e-05	0.00064	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—AGT—dilated cardiomyopathy	9.37e-06	0.000595	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	9.08e-06	0.000576	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	7.5e-06	0.000476	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	5.92e-06	0.000376	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	5.78e-06	0.000367	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	5.76e-06	0.000366	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CD36—dilated cardiomyopathy	5.63e-06	0.000357	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	5.4e-06	0.000343	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	5.25e-06	0.000334	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	5.19e-06	0.000329	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—AGT—dilated cardiomyopathy	5.06e-06	0.000322	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	4.73e-06	0.0003	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	4.61e-06	0.000293	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	4.49e-06	0.000285	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	4.04e-06	0.000257	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	3.56e-06	0.000226	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	3.47e-06	0.00022	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	3.12e-06	0.000198	CbGpPWpGaD
